Table 3.
Characteristic, n (%) | Completed Advance Directive, Active Choice Intervention | Completed Advance Directive, Control | OR (95% CI) | Interaction P Value |
---|---|---|---|---|
Age | 0.50 | |||
<26 | 57 (29.2%) | 33 (17.5%) | 1.95 (1.20-3.17) | |
26-35 | 91 (37.8%) | 57 (21.1%) | 2.27 (1.53-3.35) | |
36-45 | 47 (37.9%) | 24 (23.5%) | 1.98 (1.11-3.56) | |
>45 | 30 (36.6%) | 16 (21.1%) | 2.16 (1.06-4.41) | |
Gendera | <0.001 | |||
Female | 154 (34.5%) | 110 (23.3%) | 1.74 (1.30-2.32) | |
Male | 68 (36.6%) | 18 (12.2%) | 4.13 (2.32-7.35) | |
Race | 0.46 | |||
White | 96 (28.8%) | 65 (18.8%) | 1.74 (1.22-2.50) | |
Black | 69 (39.0%) | 39 (23.4%) | 2.09 (1.31-3.35) | |
Asian | 21 (41.2%) | 8 (19.5%) | 2.89 (1.11-7.49) | |
Mixed or other | 29 (52.7%) | 11 (22.0%) | 3.95 (1.68-9.28) | |
Prefer not to answer or missing | 10 (38.5%) | 7 (20.6%) | 2.41 (0.77-7.59) | |
Clinical degree | 0.183 | |||
No | 184 (36.8%) | 103 (20.2%) | 2.30 (1.73-3.05) | |
Yes | 41 (28.9%) | 27 (21.3%) | 1.50 (0.86-2.63) |
CI, confidence interval; OR, odds ratio.
Participants with missing gender were excluded from analysis (n = 5).